<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01960088</url>
  </required_header>
  <id_info>
    <org_study_id>13-2889</org_study_id>
    <nct_id>NCT01960088</nct_id>
  </id_info>
  <brief_title>Adolescent Vaccination in Pharmacies</brief_title>
  <acronym>AVIP</acronym>
  <official_title>Building Evidence to Expand Adolescent Vaccination in Pharmacies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines,
      including human papillomavirus (HPV) vaccine. In the first part of the study, we will
      characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in
      a national survey. In the second part of the study, we will provide HPV vaccines and other
      vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community
      pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems
      and workflow needed to provide vaccines effectively and safely, characterize parents' and
      their adolescents' attitudes toward receiving vaccine services in a pharmacy, and
      characterize pharmacists' attitudes toward providing adolescent vaccine services in a
      pharmacy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Parents' willingness to get their adolescent children HPV vaccine in pharmacy</measure>
    <time_frame>At time of study</time_frame>
    <description>Outcome is for the national survey of parents.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parents' satisfaction with HPV vaccine vaccine administration in the pharmacy</measure>
    <time_frame>At time of vaccine administration</time_frame>
    <description>Outcome is for demonstration study in a community pharmacy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1509</enrollment>
  <condition>Evaluating Attitudes Toward HPV Vaccinations in Pharmacies</condition>
  <condition>Evaluating the Provision of HPV Vaccines in a Pharmacy</condition>
  <arm_group>
    <arm_group_label>Adolescents and their parents</arm_group_label>
    <description>Pharmacy demonstration project: HPV vaccine delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HPV vaccine</intervention_name>
    <arm_group_label>Adolescents and their parents</arm_group_label>
    <other_name>Gardasil</other_name>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      N=1200 anticipated in national study N=100 anticipated in pharmacy demonstration project
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        National survey: Parents of adolescents ages 11-18. Pharmacy sample: Parents of adolescent
        boys and girls, ages 11-18 whose families reside in the Chapel Hill area, and their
        adolescents.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        NATIONAL SURVEY (probability sample)

        Inclusion Criteria:

          -  Being a member of the GfK Knowledge Panel

          -  Having a child age 11-18.

        Exclusion Criteria:

        ● None

        PHARMACY DEMONSTRATION PROJECT (convenience sample)

        Inclusion Criteria:

          -  Having an adolescent child, ages 11-18 years old, who is healthy, and for whom HPV
             vaccine is indicated

          -  Child is with the parent

        Exclusion Criteria:

        ● Being the parent of an adolescent who is immunocompromised, or has other chronic illness,
        has known anaphylactoid/hypersensitivity reactions to components of HPV vaccine used, or is
        pregnant or plan to be pregnant within a month of vaccination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noel T Brewer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Pharmacy</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Pharmacy</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2013</study_first_submitted>
  <study_first_submitted_qc>October 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2013</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adolescent vaccines</keyword>
  <keyword>HPV vaccine</keyword>
  <keyword>Pharmacies</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

